Galmed Pharmaceuticals
GLMD
$0.39
Share price
0.90%
Change (1 day)
26.32%
Change (1 year)
Categories
Galmed Pharmaceuticals (GLMD) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $2.09 M
According to Galmed Pharmaceuticals 's latest financial reports the company's total liabilities are $2.09 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Galmed Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $3.13 M | -48.62% |
| 2021-12-31 | $6.1 M | -25.77% |
| 2020-12-31 | $8.22 M | 12.93% |
| 2019-12-31 | $7.28 M | 169.25% |
| 2018-12-31 | $2.7 M | -29.68% |
| 2017-12-31 | $3.84 M | -28.41% |
| 2016-12-31 | $5.37 M | 97.76% |
| 2015-12-31 | $2.71 M | 79.05% |
| 2014-12-31 | $1.51 M | -28.29% |
| 2013-12-31 | $2.11 M | -22.77% |
| 2012-12-31 | $2.74 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | $9.64 M | 361.41% | 🇺🇸 USA |
 Endo International
ENDPQ | $11.73 B | 561,109.95% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.53 B | 25,704.50% | 🇺🇸 USA |
 Catalent CTLT | $6.30 B | 301,239.07% | 🇺🇸 USA |